Johnson & Johnson Makes $1 Billion Vaccine Deal
THURSDAY, Aug. 6, 2020 -- The U.S. government will pay Johnson & Johnson $1 billion for 100 million doses of its vaccine if it is approved by the U.S. Food and Drug Administration, the Washington Post reported Wednesday.
Johnson & Johnson has said it will offer doses at a not-for-profit cost to provide global access to the vaccine. The government can buy 200 million more doses, the Post reported. If the vaccine is approved, the company says it will make more than 1 billion doses through 2021.
"We are scaling up production in the U.S. and worldwide to deliver a SARS-CoV-2 vaccine for emergency use," Paul Stoffels, M.D., chief scientific officer at Johnson & Johnson, told the Post.
The vaccine has had promising early results. The company is now performing tests on volunteers in the United States and Belgium.
© 2020 HealthDay. All rights reserved.
Posted: August 2020
Read this next
THURSDAY, Sept. 17, 2020 -- Distribution of a COVID-19 vaccine in the United States would begin within 24 hours of its approval or emergency use authorization, and the plan is that...
THURSDAY, Sept. 17, 2020 -- There was very low influenza activity during June to August 2020 in the Southern Hemisphere, according to research published in the Sept. 18 issue of the...
THURSDAY, Sept. 17, 2020 -- Social isolation and loneliness can increase the risk for cognitive decline in seniors, according to Carla Perissinotto, M.D., geriatrician and associate...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.